drugset / Trial / NCT00017355
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Treatment
Summary
RATIONALE: Vaccines made from a patient's white blood cells mixed with tumor antigens may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic melanoma.
Timeline
- Start
- 2001-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | antigen-pulsed dendritic cell vaccine | Cell therapy | — | Subcutaneous |
| Background | filgrastim | Protein / enzyme biologic | — | Subcutaneous |